James G. Marken
2020
In 2020, James G. Marken earned a total compensation of $1.9M as Senior Vice President, Operations and Product Development at ANI Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Bonus | $276,300 |
|---|---|
| Salary | $426,267 |
| Stock Awards | $1,158,911 |
| Other | $13,057 |
| Total | $1,874,535 |
Marken received $1.2M in stock awards, accounting for 62% of the total pay in 2020.
Marken also received $276.3K in bonus, $426.3K in salary and $13.1K in other compensation.
Rankings
In 2020, James G. Marken's compensation ranked 5,807th out of 13,090 executives tracked by ExecPay. In other words, Marken earned more than 55.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,807 out of 13,090 | 56th |
Division Manufacturing | 2,389 out of 5,621 | 58th |
Major group Chemicals And Allied Products | 954 out of 2,254 | 58th |
Industry group Drugs | 826 out of 1,954 | 58th |
Industry Pharmaceutical Preparations | 615 out of 1,459 | 58th |
Source: SEC filing on April 29, 2021.
Marken's colleagues
We found five more compensation records of executives who worked with James G. Marken at ANI Pharmaceuticals in 2020.
2020
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
2020
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
2020
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
2020
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
2020
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
News
ANI Pharmaceuticals CEO Nikhil Lalwani's 2021 pay jumps 76% to $6.5M
March 25, 2022
ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
April 29, 2021
ANI Pharmaceuticals CEO Arthur Przybyl's 2019 pay jumps 39% to $5.8M
April 23, 2020
ANI Pharmaceuticals CEO Arthur Przybyl's 2018 pay rises 17% to $4.2M
April 4, 2019